Search Results 1921-1930 of 15986 for Epilepsy (Partial Onset)

1. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

   Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...

2. Publications - John M. Davis, III, M.D. - Mayo Clinic

   Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis. ACR Open Rheumatol. 2019 Dec; 1 (10):627 ...

3. Headaches in children - Diagnosis & treatment - Mayo Clinic

   Medications · OTC pain relievers. Acetaminophen or ibuprofen (Advil, Motrin IB, others) can typically relieve headaches for your child. · Prescription medications ...

4. Concussion - Diagnosis and treatment - Mayo Clinic

   Imaging may be done in people with symptoms such as bad headaches, seizures, repeated vomiting or symptoms that are becoming worse. Imaging tests may ...

5. Stroke - Doctors and departments - Mayo Clinic

   ... Epilepsy, Glioma, Carotid artery disease, Dural arteriovenous fistula, Brain AVM, Trigeminal neuralgia, Hydrocephalus, CSF leak, Astrocytoma, Brain lymphoma ...

6. Funding - Exercise Neuropsychology: Diane K. Ehlers - Mayo Clinic Research

   INVESTIGATOR & ROLE, GRANT TITLE, FUNDING SOURCE, DURATION. Diane K. Ehlers, Ph.D., principal investigator, Enhancing Cognitive Function in Breast Cancer ...

7. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   onset of menopause, must agree to use an acceptable form of birth control until 28 days following the last dose of the study drug, and females must agree to ...

8. Publications - Mark R. Pittelkow, M.D. - Mayo Clinic

   Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis. Br J Dermatol. 2022 Nov ...

9. A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects with Basal Cell Nevus Syndrome - Mayo Clinic

   ... duration of the trial except as prescribed by the Investigator. Moisturizers ... duration of the study, and for 12 months after last application of IP.

10. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    ... onset, as well as no evidence of other diseases that could explain these features. Probable PSP requires vertical supranuclear gaze palsy, prominent ...